Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016.

Shaheen KuraniMolly Moore JefferyBjorg ThorsteinsdottirLaTonya J HicksonErin F BarretoJordan HaagRachel GiblonNilay D ShahRozalina Grubina McCoy

Published in: Journal of general internal medicine (2019)

PIMs are frequently used by people with CKD, with some impact of CKD awareness on NSAID and metformin use. This may lead to adverse outcomes or hasten CKD progression, reinforcing the need for improved medication management among people with CKD.

Keyphrases

chronic kidney disease
end stage renal disease
emergency department